弓形虫Urm1基因缺失突变株(PruΔUrm1)作为小鼠弓形虫病候选疫苗的评价
本研究利用CRISPR/Cas9技术构建II型弓形虫Pru株Urm1基因缺失突变株PruΔUrm1,评估其在小鼠中的致病性和免疫保护效果。PruΔUrm1体外侵袭和增殖能力显著降低,感染小鼠100%存活且无明显症状,肝脏、脾和肺虫荷显著减少;接种PruΔUrm1可诱导TNF-α、IFN-γ和IL-10显著升高,并使小鼠抵抗I型RH株攻击,存活率达100%。
要点
- PruΔUrm1体外侵袭和增殖能力较野生型显著降低。
- PruΔUrm1感染小鼠100%存活,肝、脾、肺虫荷显著减少。
- PruΔUrm1免疫可抵抗I型RH株攻击,存活率100%。
核心结论
- PruΔUrm1免疫可对急性弓形虫感染提供有效保护,有望成为弓形虫病候选疫苗。
研究设计与样本
- 利用CRISPR/Cas9技术构建II型弓形虫Pru株Urm1基因缺失突变株PruΔUrm1,在小鼠中评估其致病性和免疫保护效果。
主要发现
- 与野生型寄生虫相比,PruΔUrm1株体外侵袭和增殖能力显著降低。
- 腹腔感染亲本Pru株的小鼠出现严重症状包括消瘦、弓背和高死亡率;感染PruΔUrm1速殖子的小鼠100%存活、无明显症状,肝脏、脾和肺虫荷显著减少。
- PruΔUrm1接种触发强烈免疫应答,TNF-α、IFN-γ和IL-10等细胞因子水平显著升高。
- PruΔUrm1免疫小鼠能抵抗I型RH野生型速殖子攻击,存活率100%,肝脏、脾和肺虫荷显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Toxoplasmosis is a significant zoonotic disease that poses a serious threat to both human and animal health. Despite ongoing research, developing an effective vaccine for toxoplasmosis remains a challenge. In this study, we evaluated the vaccine potential of the Toxoplasma Urm1 gene deletion mutant (PruΔUrm1) by assessing its pathogenicity and protective efficacy in mice. Using CRISPR/Cas9 technology, we successfully created a type II Toxoplasma gondii Pru mutant strain with a deleted Urm1 gene. Compared to the wild-type parasite, the PruΔUrm1 strain exhibited significantly reduced invasive and proliferative abilities in vitro. In in vivo studies, mice intraperitoneally infected with the parental Pru strain showed severe symptoms including emaciation, hunching, and high mortality rates. In contrast, mice infected with PruΔUrm1 tachyzoites demonstrated a 100 % survival rate, no overt symptoms, and a markedly reduced parasite burden in the liver, spleen, and lungs, indicating reduced pathogenicity. Notably, PruΔUrm1 vaccination triggered a strong immune response, characterized by significantly elevated cytokine levels, including TNF-α, IFN-γ and IL-10. Furthermore, we assessed the immunoprotective efficacy of PruΔUrm1 vaccination in mice against type I strains. Mice immunized with PruΔUrm1 were able to resist the tachyzoites of type I RH wild-type parasites, achieving a 100 % survival rate and significantly reduced parasite loads in the liver, spleen and lungs. These data demonstrate that PruΔUrm1 immunization provides effective protection against acute Toxoplasma infections and holds promise as a potential vaccine candidate for toxoplasmosis.
引用
- Bian S, Cai Q, Wang S, et al. Evaluation of the toxoplasma Urm1 gene deletion mutant (PruΔUrm1) as a promising vaccine candidate against toxoplasmosis in mice. Vaccine. 2024. PMID: 39705796. doi:10.1016/j.vaccine.2024.126632
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。